US Preventive Services Task Force Recommendation Statement: Screening for Osteoporosis to Prevent Fractures

US Preventive Services Task Force Recommendation Statement: Screening for Osteoporosis to Prevent Fractures

The US Preventive Services Task Force (USPSTF) published a systematic review to evaluate the evidence on the benefits and harms of screening for osteoporosis to prevent fractures in adults 40 years or older with no known diagnosis of osteoporosis or history of fragility fracture.


The USPSTF recommends:

  • Screening for osteoporosis to prevent osteoporotic fractures in women 65 years or older
  • Screening for osteoporosis to prevent osteoporotic fractures in postmenopausal women younger than 65 years who are at increased risk for an osteoporotic fracture as estimated by clinical risk assessment
  • Current evidence is insufficient to assess the balance of benefits and harms of screening for osteoporosis to prevent osteoporotic fractures in men


For the current recommendation, the USPSTF has noted that screening includes dual energy x-ray absorptiometry (DXA) bone mineral density (BMD), with or without fracture risk assessment.


Implementation of the aforementioned recommendations include the following:

  • Screen women 65 years or older with DXA BMD, with or without fracture risk assessment.
  • For postmenopausal women younger than 65 years, the USPSTF suggests first assessing for the presence of 1 or more risk factors for osteoporosis.
    • For women who have 1 or more risk factors, assess for increased risk using a clinical risk assessment tool.
    • For women assessed to be at increased risk, screen for osteoporosis with DXA BMD, with or without fracture risk assessment.
  • To achieve the benefit of screening to reduce morbidity and mortality from fractures, women found to have osteoporosis should be further evaluated, counseled, and, if appropriate, receive evidence-based care management.
  • There is insufficient evidence to recommend for or against screening for osteoporosis in men. Clinicians should use their clinical judgment regarding whether to screen for osteoporosis in men.

Read the article here!

Join the FFN

To help make the FFN vision a reality in your country, join the FFN – for free – today
Join FFN Today